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Possible interactions between calpain II and phospholipids such as phosphatidylinositol, phosphatidylserine and phos- 
phatidylcholine were studied using fluorescence and gel filtration techniques. Changes in fluorescence intensity of purified 
calpain II show that the enzyme strongly interacts with phosphatidylinositol and phosphatidylserine and to a lesser extent 
with phosphatidylcholine. These results are corroborated by the gel filtration technique which permits the isolation of 
the enzyme/phospholipid complex. Association between calpain II and various phospholipid vesicles can occur in the 
absence of calcium. Such binding occurs without any observable change of the molecular mass of the two subunits on 
SDS-polyacrylamide gel electrophoresis. 
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1. INTRODUCTION 
Calcium activated neutral protease (mM 
CaANP, calpain II, EC 3.4.22.17) contains two 
subunits; a large one (Mr 80000) and a smaller one 
(W 28000). Although calpain II appears to play 
important roles in various cellular events [l-4], the 
mechanism of its in vivo proteolytic activity re- 
mains to be elucidated since the enzyme is inactive 
at physiological intracellular Ca2+ concentrations. 
However, calpain II can be converted to a different 
enzymatic form by limited autolysis in the presence 
of calcium [5-81. Since autolysis greatly reduces 
the Ca2+ dependence of catalytic activity, it may 
represent an important initial step in the activation 
of the enzyme. This activation step may be in- 
itiated or regulated by a combination of Ca*+ and 
phospholipids because some phospholipids such as 
phosphatidylinositol and, to a lesser extent, a 
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metabolic derivative dioleoylglycerol stimulate in 
vitro the Ca*+-dependent autolysis by reducing the 
amount of Ca*+ necessary [S-lo]. The mechanism 
of enzyme phospholipid interactions is unknown at 
present. According to recent regulation models 
[ll, 121 the presence of Ca*+ is necessary for cal- 
pain II-membrane binding. In order to investigate 
this phenomenon two techniques were used, the 
first (fluorescence) providing information on 
structural changes induced by the association with 
phospholipids, the second (gel filtration) permit- 
ting the recovery of the complexes. The studies 
described here show that purified calpain II can 
bind phosphatidylinositol, phosphatidylserine and 
phosphatidylcholine in the absence of Ca*+: the 
dissociation constants (Kd) are respectively 4 x 
10m9, 5 x 10m9 and 10e8 M. These calpain II- 
phospholipid associations were confirmed by gel 
filtration techniques using a Sepharose 4B column: 
our results demonstrate that calpain II can only 
bind small unilamellar phospholipid vesicles. In 
the presence of phosphatidylinositol, phosphati- 
dylserine and phosphatidylcholine, respectively 
75%, 75% and 25% of calpain II was found to be 
associated. 
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2. MATERIALS AND METHODS 
Unless indicated, all chemicals and reagents were from Sigma 
in the highest grade available. Casein was obtained from Merck 
(art.2244). L-3-Phosphatidyl[2-‘Hlinositol (17.9 Ci/mmol), 
1 ,2-dioleoyl-L-3-phosphatidyl-L-[l-’4C]serine (30 mCi/mmol) 
and I-palmitoyl-2-[ 1-‘4C]linoleoyl-L-3-phosphatidylcholine 
(50 mCi/mmol) were purchased from Amersham. Phenyl- 
Sepharose 4B and MonoQ, (HR 5/5) were obtained from 
Pharmacia. 
Calpain II was prepared from rabbit skeletal muscle using the 
procedure of Penny et al. [l l] partly modified by the use of an 
HPLC anion-exchange column (MonoQ, HR5/5) for the final 
purification step. The specific activity of purified calpain II was 
9000 U/mg. Protein was determined by the method of Brad- 
ford [ 131 using the Bio-Rad reagent and BSA as standard. Pro- 
teolytic activity was measured with alkali-denatured casein as 
substrate according to Penny et al. [l 11. The enzymatic unit was 
defined as described [14]. 
The phospholipids were dried from the organic solvent under 
a stream of nitrogen and then suspended in a 20 mM Tris-HCI 
buffer, pH 7.50, containing 1 mM EDTA (buffer A) and sub- 
jected to a direct probe sonication (60 s). This procedure 
resulted in the production of mainly single unilamellar small 
vesicles. 
Binding of calpain II to the phospholipid vesicles was 
estimated from changes in the protein fluorescence intensity on 
excitation at h = 280 nm, using as SLM 8.000 spec- 
trofluorometer and 10 mm cells. The decrease of the maximum 
fluorescence intensity at 333 nm as a function of phospholipid 
addition was ascribed to calpain II-phospholipid binding. The 
data are reported as the relative change in emission intensity 
(l,, - [)/I.,; I, represents the fluorescence intensity of the protein- 
lipid complex and I, the intensity of the protein alone. The 
association constants (Ka) and the number of phospholipid 
molecules bound per enzyme molecule (PL/B) were calculated 
according to [15] using the Scatchard method. Ka can be related 
to the molar ratio (Ri) = (PL/E) by the general relationship: 
cu/[(l - m)P&t] = Ka (l/n -cu/Ri), where (Y is the enzyme 
bound fraction; (1 - cu) the free enzyme fraction; PO the total 
enzyme concentration; and n the number of phospholipid 
molecules needed for defining a lipid binding site for calpain II. 
SDS-gel electrophoresis was performed according to the pro- 
cedure of Laemmli [16], using a stacking gel of 4% (w/v) 
acrylamide and a gradient polyacrylamide resolving gel 
(lo-20%, w/v). Radioactivity was measured using Ready-solv 
EP scintillation fluid (Beckman) in a Beckman LS 1800 scin- 
tillation counter. 
3. RESULTS 
3.1. Evidence for phospholipid-calpain II 
interactions by fluorescence 
The direct detection of phospholipid-calpain II 
binding is reported in fig.1 at a calpain II concen- 
tration of 70 nM. As can be seen the fluorescence 
yield of tryptophan residues of the protein 
decreases, following the addition of the various 
200 300 
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Fig. 1. Relative changes in the fluorescence intensity (h = 333 nm) of calpain II versus the (phospholipid)/(enzyme) molar ratio. Calpain 
II concentration was 70 x 10m9 M in buffer A. ( M) Phosphatidylinositol vesicles, (H) phosphatidylserine vesicles, (w) 
phosphatidylcholine vesicles. All the experiments were carried out at 10°C and each value is an average of 3 experiments. 
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phospholipids. Structural changes of calpain II 
show that each phospholipid can interact with the 
protein. Whatever the phospholipid used, the 
binding curve reaches a saturation plateau for high 
molar ratios (PL/E). The final quenching of 
fluorescence for acidic phospholipids is stronger 
(30-40%) compared to the very weak, although 
significant quenching observed with phosphatidyl- 
choline. Plotting these data according to the 
Scatchard method (cf. section 2), allows the 
estimation of Kd values which are rather similar for 
both phosphatidylinositol and phosphatidylserine- 
calpain II complexes (fig.2) about 5 x 10m9 M). 
Despite a large uncertainty the affinity for phos- 
phatidylcholine is about an order of magnitude 
weaker (lo-* M) (fig.2). Experiments carried out 
at different calpain II concentrations (25 x 10v9 
M, 90 x 10m9 M) are consistent with these deter- 
minations. So far, for phosphatidylinositol and 
phosphatidylserine, binding appeared to be of a 
relatively high affinity and the association rate was 
rapid on the time scale of the experiments. The 
number of phospholipid molecules needed to 
define a binding site for calpain II varies from 
about 100 negatively charged phosphatidylserine 
or phosphatidylinositol molecules to a lower value 
of about 40 for phosphatidylcholine. Thus, both 
from the quantum yield of the bound state and the 
binding parameters it appears that calpain II binds 
differently to these two types of phospholipid in- 
terfaces. 
3.2. Recovery of enzyme-phospholipid complexes: 
elution profiles of the Sepharose 4B column 
and SDS-gel electrophoresis analysis 
Fig.3A-C, shows that each labelled 
phospholipid is eluted from the Sepharose 4B col- 
umn in two different peaks. According to Huang 
[ 171 and Dufourcq et al. [ 181, these two peaks cor- 
respond, respectively, to multilamellar phospho- 
lipid vesicles (Mr > IO-‘) eluted in the void volume 
and unilamellar phospholipid vesicles eluted in the 
inclusion volume (fractions 32-33) with a diameter 
of about 200 A. As can be seen in fig.3A, in the 
presence of phosphatidylinositol vesicles, about 
75% of bound calpain II molecules, based on pro- 
tein concentration, were eluted in the unilamellar 
phospholipid vesicle elution volume of the column 
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Fig.2. Scatchard plots of the data from fig.1 concerning the calpain II-phospholipid interactions. ( -) Phosphatidylinositol, 
(M) phosphatidylserine, (A--A) phosphatidylcholine. 
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Fig.3. Sepharose 4B elution pattern of calpain I1 (A) and calpain II-phospholipid complexes (A, B and C). After sonication, 50 pl 
of the appropriate phospholipids (4 mg/ml) labelled with L-3-phosphatidy1-[2-3H]inositol (800 dpm/nmol) or 1,2-dioleoyl- 
L-3-phosphatidyl-L-[1-‘4C]serine (450 dpm/nmol) or 1-palmitoyl-2-[l-‘4C]lino1eoyl-L-3-phosphatidy1choline (150dpm/nmol) in 
buffer A were incubated at 10°C with 750 ,uI of purified calpain II (0.080 mg/ml) and applied to a Sepharose 4B column (40 x 1 cm) 
previously equilibrated with buffer A. The column fractions (600 ~1) were assayed for ( n - -- n ) protease concentration, when calpain 
II is chromatographed alone (A) or for both (M) protein concentration, and (M) radioactivity measures (A,B,C) when 
calpain II was chromatographed in the presence of phospholipids. SOpI aliquots from tubes 32-33 and 150 ~1 from tubes 41-42 were 
heated at 100°C for 2 min in the presence of 1% SDS and subjected to electrophoresis (inset). (A) Phosphatidylinositol vesicles; (B) 
phosphatidylserine vesicles; (C) phosphatidylcholine vesicles. 
and 25% of free calpain II molecules in the free 
calpain II elution volume. From the inset (fig.3A) 
bound (fractions 32-33) and free calpain II (frac- 
tions 41-43) consist of 80 and 28 kDa subunits. 
From the phosphatidylserine and phosphatidyl- 
choline vesicle elution profiles (fig.3B and C, 
respectively), it can be observed that 75’Yo and 25% 
of bound calpain II molecules were in the uni- 
lamellar phospholipid vesicle elution volume. So 
far calpain II molecules were found to be bound 
only with small unilamellar phospholipid vesicles. 
4. DISCUSSION 
In vitro the autolytic process of calpain II in- 
volving phospholipids and Ca2+ is relatively well 
known whereas in vivo the mechanism of regula- 
tion remains hypothetical [10,19,20]; the first ac- 
tivation step involving CaL+ dependence of the 
enzyme-membrane interactions is still unclear. In 
order to clarify the calpain II membrane associa- 
tion, we studied the binding of calpain II to 
charged and neutral phospholipid vesicles. Our 
fluorescence data demonstrate that Ca2+ are not 
necessary for the binding of the enzyme to 
phospholipids. Assuming a simple equilibrium be- 
tween free and bound enzyme the affinity of cal- 
pain II for the interface was estimated to be about 
5 x 10e9 M for phosphatidylserine and 
phosphatidylinositol with about 100 phospholipid 
molecules being required for defining a site. This 
affinity for the uncharged lecithin interface is 
weaker. Gel filtration results have shown that 
about 75% of calpain II was bound to charged 
phospholipids and 25% was bound to non-charged 
phospholipids: in the same experimental condi- 
tions but with mixed phospholipid vesicles (con- 
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taming 20% of PI, 20% PS and 60% PC) the 
interactions were also found to be significant (not 
shown). Taken together these results suggest hat 
ionic and hydrophobic interactions could be in- 
volved in the calpain II-phospholipid complexes. 
This also confirms results indicating that calpain II 
possesses in its native form Ca’+-independent 
weakly hydrophobic accessible region [21]. Thus, 
even in the absence of Ca2+, it can be suggested 
that intracellularly a fraction of calpain II 
molecules could be permanently bound to mem- 
brane phospholipids. Local increases of Ca2+ con- 
centration, producing some structural modifica- 
tions of calpain II such as exposure of strongly 
hydrophobic areas, could modify the membrane- 
enzyme interactions [8] (with for example possible 
accessibility to the biological substrates such as 
kinase C [19]) and promote the autocatalytic ac- 
tivation of the enzyme according either to current- 
ly proposed or as yet unknown mechanisms. 
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